Switching From Natalizumab To Immune Reconstitution Therapies In Patients With Multiple Sclerosis
AuthID
P-00Z-KCM
P-00Z-KCM
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service